drugset / Trial / NCT04709601

Efficacy and Mechanism of Action of Methenamine Hippurate (Hiprex™) in Women With Recurring Urinary Tract Infections.

NCT04709601

Phase 4 Terminated 14 enrolled University of Texas Southwestern Medical Center
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to measure the concentration of formaldehyde in the urine of women with recurrent urinary tract infections on Hiprex; and then, assuming its urinary presence is confirmed at the proper acid urinary pH, evaluate if such a therapy has favorable effects in decreasing the rate of recurrent urinary tract infections over time.

Timeline

Start
2021-01-04
Primary completion
2024-12-31
Completion
2024-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Methenamine Hippurate Unknown 1 g Oral